Stay updated on Organon & Co. Press Releases

Sign up to get notified when there's something new on the Organon & Co. Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Organon & Co. Press Releases page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A new news item 'Organon To Present at the Piper Sandler 37th Annual Healthcare Conference' was added, and an older item 'Organon To Report Second Quarter 2025 Results and Host Conference Call on August 5, 2025' was removed.
    Difference
    3%
    Check dated 2025-12-01T19:52:27.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a November 17, 2025 press release about POHERDY FDA approval and removed the July 7, 2025 VTAMA guidelines item.
    Difference
    4%
    Check dated 2025-11-17T17:23:39.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    New November 2025 press releases added to the News page, including Organon's Q3 2025 results and data on VTAMA. Some older 2025 entries were removed from the listing.
    Difference
    11%
    Check dated 2025-11-10T13:44:08.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    New press release dated October 27, 2025 is added to the News page, announcing Joseph Morrissey as Interim CEO and Carrie Cox as Executive Chair and detailing the Audit Committee investigation results. The listing now shows pagination '1-10 of 126' on the page.
    Difference
    7%
    Check dated 2025-11-03T11:46:48.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    New regulatory approval news replaces a former quarterly results announcement, adding Henlius/Organon biosimilar approvals and removing the 2025 Q1 results/news item.
    Difference
    11%
    Check dated 2025-09-21T06:42:17.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The page now includes the FDA's approval of Henlius and Organon's biosimilars BILDYOS® and BILPREVDA®, while the previous mention of Organon's acquisition of TOFIDENCE™ has been removed.
    Difference
    13%
    Check dated 2025-09-06T21:08:20.000Z thumbnail image

Stay in the know with updates to Organon & Co. Press Releases

Enter your email address, and we'll notify you when there's something new on the Organon & Co. Press Releases page.